Aptinyx Inc reported $112.04M in Equity Capital and Reserves for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 566.96M 2.12M
Acorda Therapeutics ACOR:US $ 164.48M 26.01M
Adamas Pharmaceuticals ADMS:US -21606000 17.57M
Biogen BIIB:US $ 10429.9M 322M
Cara Therapeutics CARA:US $ 207.19M 3.72M
Daiichi Sankyo 4568:JP Y 1312228M 32130M
Eli Lilly And LLY:US $ 7757M 1312.6M
Gw Pharmaceuticals GWPH:US $ 736.37M 4.72M
Halozyme Therapeutics HALO:US $ 281.67M 161.93M
Intra Cellular Therapies ITCI:US $ 486.76M 66.83M
IONIS PHARMACEUT IONS:US $ 531M 51.67M
Marinus Pharmaceuticals MRNS:US $ 78.49M 16.57M
Neurocrine Biosciences NBIX:US $ 1346M 66.8M
Novartis NOVN:VX SF 56771M 2729M
Ultragenyx Pharmaceutical RARE:US $ 933.67M 38.5M
Vertex Pharmaceuticals VRTX:US $ 9530.71M 334.31M